COVID-19

Nearly one-third of hospital personnel had still not been vaccinated against COVID-19 by mid-September.

The EUA amendment was granted for both the Pfizer-BioNTech and Moderna vaccines.

The EUA submission includes data from the company’s interim analysis of the Phase 2/3 EPIC-HR clinical trial.

Misinformation about the disease and vaccinations remains widespread, and correlated with party affiliation.

Not every vaccine is required, some are just strongly recommended. Here's what to know about 5 recommended vaccines.

The vaccine mandate applies to employees at facilities that participate in the Medicare and Medicaid insurance programs.

Although the authors say their findings shed light on possible disruptions to insulin supply during COVID-19, they note they could not adjust for those with diabetes who died.

The company plans to submit these results to the FDA and EMA for review.

After a panel federal judges put a temporary halt on the mandate, the U.S. Surgeon General says the administration is ready to fight for the requirement.

Patients with post-acute COVID syndrome, or “long COVID,” can experience symptoms for at least 12 months, investigators reported.

Here’s a roundup of the latest news from Drug Topics®.

"The spread of misinformation and mistrust in doctors and science is contributing to staggeringly low vaccination rates among pregnant people," said the American Colleges of Obstetricians and Gynecologists.

The FDA and CDC have both issued their respective recommendations for the rollout of Pfizer-BioNTech and Moderna COVID-19 vaccine boosters.

Merck and Ridgeback Biotherapeutics have announced their submission of an EUA application to the FDA for an oral antiviral medication for the treatment of COVID-19.

Prioritizing well-being can be difficult when dealing with increased workloads, but pharmacists can find small ways to incorporate self-care into their days.

Good Neighbor Pharmacy (GNP) has allocated more than 2 million doses of COVID-19 vaccines to more than 1500 independent pharmacies through its partnership with the Federal Retail Pharmacy Program.

The FDA EUA for the COVID-19 vaccine will remain in effect for those 12 to 15 years of age and for the administration of a third dose.

A study published in JAMA Internal Medicine explained that a first dose reaction to COVID-19 vaccination should not deter people from receiving their second dose.

The remote and virtual way of treating patients is becoming the new norm. Specialty providers have to adapt to provide the most streamlined solutions.

A new study published in Pediatrics showed a decrease in prescription drug dispensing for children during the COVID-19 pandemic, including for infection-related medicines and chronic disease treatments.

Stanford study indicates that immune cells respond better to COVID-19 infection when patients have already been exposed to other, less deadly coronaviruses.

"Patient care doesn't stop with COVID-19"

Johnson & Johnson released a statement providing more information on the risks and benefits of its single-shot COVID-19 vaccine.

Patients with cancer with complete COVID-19 vaccinations demonstrated a high rate of antibodies, according to the study.

Pharmacists reflect on their takeaways from the experience and how to move forward.

Administering pediatric immunizations can be a window of opportunity for pharmacists to demonstrate their value.

In part 2 of our interview, Jason Ausili, PharmD, speaks to the challenges of COVID-19 vaccination processes and dives into technology solutions for these workflow barriers.

The RECOVERY study demonstrated that an antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for COVID-19 antibody treatments.

Many Americans still do not want to get vaccinated. Vaccine myths spread on the internet are a major part of the problem.

Novavax’s recombinant nanoparticle protein-based COVID-19 vaccine showed an overall efficacy of 90.4% and 100% efficacy against moderate and severe disease.